Let's Talk Risk!

Home
Podcast
QMSR Compliance
Wall of Love
Archive
About
Delay in treatment can be deadly; analyze it carefully
There are many recalls and FDA warning letters related to delay in treatment caused by medical device malfunctions. Here are a few considerations to…
 • 
Naveen Agarwal, Ph.D.
Quick Tip: Create a safe environment to foster collaboration
Insight from a conversation with Dr. Mark Armstrong
LTR Weekly Digest #35 - 4th May, 2024
Catch up on this week's articles - Webinar recording, a clinician's view on AI/ML enabled medical devices, and a quick tip about QMSR.
 • 
Naveen Agarwal, Ph.D.
3:58
LTR 49: A clinician's view on AI/ML enabled medical devices
Insights from a Let's Talk Risk! conversation with Dr. Emanuel Tkach
34:41
Webinar 8: Case study discussion and Q&A
Watch now | A case study about a warning letter for miscalculating risk and a general Q&A session about risk management.
 • 
Naveen Agarwal, Ph.D.
56:41

April 2024

Quick Tip: Treat QMSR practically as ISO 13485 international standard
Insight from a conversation with Vincent F. Cafiso
LTR Weekly Digest #34 - 27th April, 2024
Catch up on this week's articles - 5 frequently asked questions about QMSR, integrating purchasing controls across product lifecycle, and a quick tip to…
 • 
Naveen Agarwal, Ph.D.
4:03
LTR 48: Integrating purchasing controls across product lifecycle
Insights from a Let's Talk Risk! conversation with Kevin Posey
3
34:38
Quick Tip: Don't ignore quality of life benefit of your medical device
Insight from a conversation with Ronald Baumans
 • 
Naveen Agarwal, Ph.D.
LTR Weekly Digest #33 - 20th April, 2024
Catch up on this week's articles - LTR podcast on cloud computing and connected devices, FDA approvals, recalls, warning letters, and a quick tip to…
 • 
Naveen Agarwal, Ph.D.
5:04
LTR 47: Cloud computing in MedTech, evolving regulatory landscape and career tips with Randy Horton
Deep insights from a conversation with Randy Horton
 • 
Naveen Agarwal, Ph.D.
58:45
Medical Device News Update - March 2024
FDA approvals, warning letters and Class I recalls issued during March 2024
 • 
Naveen Agarwal, Ph.D.
© 2024 Naveen Agarwal, Ph.D.
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture